VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
ARX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
ARXAccelerant Holdings
$19.90$4.3B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksARXBalance Sheet

Accelerant Holdings (ARX) Balance Sheet

5Y historyFree accessUpdated daily

Equity of $731.9M against $8.7B of total liabilities implies roughly 11.9x leverage, leaving limited capital buffer if reserves develop adversely.

Income StatementBalance SheetCash FlowRatios

ARX Balance Sheet

Annual statement

ARX Balance Sheet

Accelerant Holdings (ARX) balance sheet — 5-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21
Total Assets9.46B8.26B6.09B3.74B2.2B1.16B
Asset Growth %104.31%35.57%63.09%69.94%90.32%-
Total Investment Assets4M806.4M602.9M247.5M273.4M150M
Long-Term Investments970.1M94.4M538.1M239.5M210.6M111.8M
Short-Term Investments508.3M712M64.8M8M62.8M38.2M
Total Current Assets3.77B7.74B5.25B3.28B1.81B909.5M
Cash & Equivalents2.1B1.8B1.23B775.4M446.2M301.9M
Receivables10.52B3.4B3.73B2.27B659.2M295.2M
Other Current Assets-2.93B0214.6M223.4M00
Goodwill & Intangibles1.03B292.5M147.6M120.6M119.7M74.3M
Goodwill063.1M30.9M20.7M18.3M12.6M
Intangible Assets219.7M229.4M116.7M99.9M101.4M61.7M
PP&E (Net)000000
Other Assets-211.9M54.4M157.5M93M51.4M56.5M
Total Liabilities8.7B7.54B5.67B3.45B1.85B899.4M
Total Debt119.5M121.3M121.4M120.3M100.5M49.9M
Net Debt-1.99B-1.68B-1.1B-655.1M-345.7M-252M
Long-Term Debt119.5M121.3M120.6M120.3M100.5M49.9M
Short-Term Debt00800K000
Total Current Liabilities8.34B7.2B541.8M101.1M1.81B816.8M
Accounts Payable2.02B1.52B13.8M9.5M277.4M192.2M
Deferred Revenue02.16B00828.1M364.9M
Other Current Liabilities6.26B3.46B425.5M0604.1M185.5M
Deferred Taxes000000
Other Liabilities4.53B-18.6M5.01B3.23B-144.6M32.7M
Total Equity761M726.4M427M286.7M350M256.1M
Equity Growth %211.35%70.12%48.94%-18.09%36.67%-
Shareholders Equity731.9M697.7M408.7M310.5M354.5M257.9M
Minority Interest29.1M28.7M18.3M-23.8M-4.5M-1.8M
Retained Earnings-1.48B-1.54B-182.8M-210M-161.2M-69.5M
Common Stock000000
Accumulated OCI-9.1M2.2M-19.5M-7.5M-10.9M8.1M
Return on Equity (ROE)8.21%-234.8%7.62%-15.33%-30.26%-8.4%
Return on Assets (ROA)0.69%-18.86%0.55%-1.64%-5.47%-1.86%
Equity / Assets8.05%8.79%7.01%7.67%15.92%22.16%
Debt / Equity0.16x0.17x0.28x0.42x0.29x0.19x
Book Value per Share3.503.821.971.322.111.18
Tangible BV per Share2.492.281.290.771.390.84

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Reserve adequacy and adverse selection

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Equity Rebuilding Lags Asset Expansion

Based on EDBL's reported figures, ARX's total assets expanded from $5.5B in 2024Q3 to $9.5B in 2026Q3 while equity reached only $731.9M, a ratio suggesting the balance sheet is growing far faster than the capital base supporting it.

Total liabilities rose in step with assets, leaving equity at roughly 7.7% of total assets in the latest quarter, which appears thin for a carrier with a liability-heavy structure. The equity base has grown only modestly relative to liabilities, indicating that expansion has been financed largely through policyholder-related obligations rather than retained earnings. Investors should monitor whether capital generation can keep pace with premium-driven balance sheet growth.

Investment Portfolio Visibility Remains Limited

As reported in the supplied quarterly figures, ARX shows total investments of only about $1.0M against total assets near $9.5B, a gap that makes the composition and yield of the invested asset base impossible to assess from available data.

The reported investments line appears inconsistent with the scale of the balance sheet, and investment income and yield fields are absent across all periods, so data is unavailable for allocation, duration, or unrealized loss analysis. This gap may reflect how the company classifies its portfolio rather than an actual absence of earning assets. Until the investment book is disclosed clearly, the portfolio's contribution to earnings should be treated as unverified.

Reserve Volatility Versus Stable Loss Ratios

Based on reported figures, ARX's loss ratio ranged from 26.2% in 2025Q3 to 44.3% in 2024Q4, yet a roughly $1.4B net loss in 2025Q3 suggests reserve or accrual movements that the loss ratio alone does not explain.

The gap between a modest quarterly loss ratio and a very large reported net loss suggests that reserve development or non-underwriting accruals may be driving results. Combined ratios swinging from 83.4% to 101.1% within a year point to unstable underwriting outcomes. Investors should monitor reserve development disclosures closely, as reserve adequacy cannot be confirmed from the supplied data.

Thin Capital Against Rapid Liability Growth

According to reported financial statements, ARX's equity of $731.9M against total liabilities of $8.7B implies a leverage ratio of roughly 11.9 times, a position that leaves limited buffer if reserves develop adversely.

Regulatory statutory capital ratios such as RBC are not disclosed in the supplied data, so capital adequacy must be inferred from the book equity relationship alone. Return on equity has oscillated between negative and low single digits, which limits the pace at which internal capital can rebuild. Capacity for buybacks or acquisitions appears constrained, and capital retention should be treated as a priority until statutory solvency metrics are visible.

Underwriting Breakeven Masks Adverse Selection

Based on reported figures, ARX's combined ratio near 100% and 42.4% loss ratio in 2026Q1 may understate risk if MGA-sourced business is adversely selected, a possibility the supplied data cannot confirm or rule out.

Business written through managing general agents may carry higher adverse selection risk than direct placements, which could push future loss ratios above current levels with a lag. Because claims outflows track premium growth, the apparent stability in underwriting may reflect the timing of recognition rather than durable risk quality. Investors should watch whether loss emergence in later periods confirms or contradicts the current picture.

ARX — Frequently Asked Questions

Quick answers to the most common questions about buying ARX stock.

What are the total assets of Accelerant Holdings (ARX)?

As of 2025, Accelerant Holdings (ARX) had total assets of $8.26B including $7.74B in current assets.

How much debt does Accelerant Holdings (ARX) have?

Accelerant Holdings (ARX) carries total debt of $121.3M, offset by $2.51B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Accelerant Holdings?

Accelerant Holdings (ARX) has total shareholders' equity (book value) of $697.7M ($3.82 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Accelerant Holdings's current ratio and liquidity?

Accelerant Holdings (ARX) reported a current ratio of 1.08x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.